title: Augmentation of tumor-specific immunity by upregulation of apoptotic melanoma cell calreticulin expression.
authors.affiliation: Duke University Medical Center, Durham, NC, USA. paul.mosca@duke.edu
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Mosca
authors.forename: Gavin P
authors.initials: GP
authors.lastname: Robertson
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D017951:Antigen Presentation; D017209:Apoptosis / Q000276:immunology*; D037282:Calreticulin / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000276:immunology / Q000627:therapeutic use; D000074324:Ipilimumab; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D010587:Phagocytosis / Q000276:immunology; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D037282:Calreticulin; D007376:Interleukin-2; D000074324:Ipilimumab